Table 12. N-Glycan Profiling in Patients With Gastric Carcinoma Based on TNM Stage.
| Mean ± SD |
|
|||||
|---|---|---|---|---|---|---|
| Variable | Stage I (n=22) | Stage II (n=28) | Stage III (n=63) | Stage IV (n=25) | F | P |
| Peak 1a | 7.94±1.87 | 7.83±3.21 | 8.21±2.54 | 8.82±3.44 | 0.600 | 0.616 |
| Peak 2a | 1.21±0.38 | 1.24±0.51 | 1.23±0.42 | 1.67±0.49 | 1.108 | 0.348 |
| Peak 3a | 6.09±1.16 | 5.75±1.25 | 5.61±1.12 | 5.83±1.79 | 0.770 | 0.513 |
| Peak 4a | 5.81±0.85 | 5.97±0.74 | 5.63±0.79 | 5.78±0.96 | 1.116 | 0.345 |
| Peak 5a | 40.36±4.10 | 42.25±4.45 | 43.12±4.21 | 41.31±4.28 | 2.646 | 0.052 |
| Peak 6a | 19.66±3.09 | 17.13±2.45 | 16.33±2.68 | 15.99±2.78 | 9.258 | <0.001 |
| Peak 7a | 5.72±1.17 | 5.30±1.05 | 5.14±1.25 | 4.82±1.22 | 2.312 | 0.079 |
| Peak 8a | 7.49±1.74 | 7.43±1.88 | 7.41±1.73 | 7.58±2.18 | 0.049 | 0.986 |
| Peak 9a | 2.67±1.58 | 3.97±1.80 | 4.17±1.33 | 4.84±2.27 | 6.834 | <0.001 |
| Sumfucb | 46.43±4.77 | 43.21±5.55 | 42.14±6.94 | 42.91±6.94 | 2.944 | 0.036 |
Abbreviations: SD, standard deviation.
a analyses of variance
b Sumfuc indicates the total abundance of α-1,6-fucosylated structures.